Femasys Inc. is a privately held medical technology company transforming women’s healthcare worldwide by developing a platform of innovative, in-office gynecological solutions. Femasys’ reproductive health portfolio includes FemVue®, a device that introduces a mixture of saline and air contrast “bubbles” that are highly visible under ultrasound allowing physicians to accurately evaluate the fallopian tubes in the convenience of their office. For more information, please visit www.femvue.com.